Ask AI
PBC Consult
PBC Consult: Customized Treatment Recommendations for Individual Patient Cases

Pharmacists: 0.25 contact hour (0.025 CEUs)

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 0.25 Nursing contact hour

Released: March 31, 2026

About This Tool & Disclaimer

PBC Consult: Customized Treatment Recommendations for Individual Patient Cases

The goal of the tool is to educate healthcare professionals on making optimal management choices for patients with primary biliary cholangitis (PBC) who are already receiving first-line therapy.

A series of questions allows the participant to select individual patient characteristics that are necessary to consider when making management choices. These characteristics include biochemical markers, laboratory values, complications (eg, cirrhosis), and symptoms.

These are not exclusive characteristics when selecting optimal treatment for patients with PBC. Other considerations that are not included in this tool, such as the presence of various comorbidities and any concurrent medications, should also be considered when appropriate for making management decisions.

This tool assumes we have a patient with a confirmed diagnosis of PBC who has already started appropriately weight-based ursodeoxycholic acid, with no additional features or specific comorbidities that would affect treatment choice other than those described when entering the patient details. Based on the characteristics entered, the tool will display recommendations for that specific patient case.

For additional information on best practices in the management of patients with PBC, follow the link for online modules and commentaries from expert faculty.

This program is supported by an educational grant from Gilead Sciences.

© 2026 Clinical Care Options, LLC dba Decera Clinical Education. All rights reserved.

Access to and use of this Interactive Decision Support Tool titled, “PBC Consult: Customized Treatment Recommendations for Individual Patient Cases" is provided subject to the following terms and conditions. PLEASE READ THESE TERMS CAREFULLY.

This Interactive Decision Support Tool is designed to educate healthcare professionals on making optimal management choices for patients with primary biliary cholangitis (PBC) who are already receiving first-line therapy. The information provided is based on the expert guidance of Alan Bonder, MD, AGAF; Aparna Goel, MD; Sonal Kumar, MD, MPH; Daniel S. Pratt, MD, FAASLD; and Mark Swain, MD, MSc, FRCPC, FAASLD, FCAHS.

The material published by Decera Clinical Education reflects the views of the reviewers or authors of the CCO material, not those of Decera Clinical Education, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the FDA. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Although the information contained in the “PBC Consult: Customized Treatment Recommendations for Individual Patient Cases” Interactive Decision Support Tool has been produced and processed from sources believed to be reliable, no warranty, expressed or implied, is made regarding the accuracy, adequacy, completeness, legality, reliability, or usefulness of any information. This disclaimer applies to both the isolated and aggregate uses of the information. Decera Clinical Education provides this information on an as-is basis. This disclaimer applies to all material published by Decera Clinical Education including, but not limited to, medical information or opinions. All warranties of any kind, expressed or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose, freedom from contamination by computer viruses, and noninfringement of proprietary rights are disclaimed.

Any trademarks are the property of respective companies.

© 2026 Clinical Care Options, LLC dba Decera Clinical Education. All rights reserved.

Program Content